4//SEC Filing
Esser Eric Eugene 4
Accession 0000950170-24-046095
CIK 0001850079other
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 5:08 PM ET
Size
7.5 KB
Accession
0000950170-24-046095
Insider Transaction Report
Form 4
Telesis Bio Inc.TBIO
Esser Eric Eugene
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2024-04-17+200,000→ 200,000 totalExercise: $0.38Exp: 2034-04-17→ Common Stock (200,000 underlying) - Award
Common Stock
2024-04-17+100,000→ 129,260 total
Footnotes (2)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through each applicable vesting date, 50% of the RSUs shall vest on April 17, 2025, and the remaining 50% of the RSUs shall vest on April 17, 2026.
- [F2]Subject to the Reporting Person's continuing as a Service Provider (as defined in the Plan) through each applicable vesting date, 25% of the shares subject to the option shall vest on April 17, 2025, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.
Documents
Issuer
Telesis Bio Inc.
CIK 0001850079
Entity typeother
Related Parties
1- filerCIK 0001933819
Filing Metadata
- Form type
- 4
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 5:08 PM ET
- Size
- 7.5 KB